| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 704562 | Null | 0.0135588245836371 | 0.36546816 |
| NSC 715724 | Null | 0.0135588245836371 | 0.15724033 |
| NSC 719407 | Null | 0.0135588245836371 | 0.020974592 |
| NSC 727729 | 1, 1'[Pentane-1,5-diyl)dioxy]bis(11as)-2-fluoro-7-methoxy-1,2,3 ,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one | 0.0135588245836371 | 0.32954063 |
| NSC 732737 | Null | 0.0135588245836371 | 0.44071843 |
| NSC 733891 | arypurine derivatives | 0.0135588245836371 | 0.31325675 |
| NSC 736624 | Indenoisoquinoline derivative | 0.0135588245836371 | 0.42945946 |
| NSC 741106 | 6-(3-Aminopropyl)-5,6-dihydro-9-methoxycarbonyl-3-nitro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride | 0.0135588245836371 | 0.33010534 |
| NSC 658142 | 2-(1-(4-(2-Pyridyl)piperazino))naphthazarin | 0.0141354818755237 | 0.38984409 |
| NSC 684836 | Butanamide, N-[2-[(4-fluorophenyl)amino]-1,1,1,3,3,3- hexafluoro-2-propyl]- | 0.0141354818755237 | 0.31151729 |